entinostat has been researched along with Obesity in 2 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " MS-275 and liraglutide combined therapy improved fasting glycemia upon short-term treatment and a chronic administration causes a reduction of obesity in DIO mice." | 1.56 | MS-275, a class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism to improve glycemic control and reduce obesity in diet-induced obese mice. ( Adalla, V; Bele, S; DiMarchi, R; Girada, SB; Gupta, A; Ibrahim, A; Kalivendi, SV; Katika, MR; Mitra, P; Oruganti, S; Prakash Babu, P; Puri, V; Ray, A; Rayalla, RS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bele, S | 1 |
| Girada, SB | 1 |
| Ray, A | 1 |
| Gupta, A | 1 |
| Oruganti, S | 1 |
| Prakash Babu, P | 1 |
| Rayalla, RS | 1 |
| Kalivendi, SV | 1 |
| Ibrahim, A | 1 |
| Puri, V | 1 |
| Adalla, V | 1 |
| Katika, MR | 1 |
| DiMarchi, R | 1 |
| Mitra, P | 1 |
| Ferrari, A | 1 |
| Fiorino, E | 1 |
| Longo, R | 1 |
| Barilla, S | 1 |
| Mitro, N | 1 |
| Cermenati, G | 1 |
| Giudici, M | 1 |
| Caruso, D | 1 |
| Mai, A | 1 |
| Guerrini, U | 1 |
| De Fabiani, E | 1 |
| Crestani, M | 1 |
2 other studies available for entinostat and Obesity
| Article | Year |
|---|---|
MS-275, a class 1 histone deacetylase inhibitor augments glucagon-like peptide-1 receptor agonism to improve glycemic control and reduce obesity in diet-induced obese mice.
Topics: Animals; Benzamides; Blood Glucose; Glucagon-Like Peptide-1 Receptor; Glycemic Control; Histone Deac | 2020 |
Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases.
Topics: Adipocytes, Brown; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Benzamides; Diet, High-Fat | 2017 |